Patient Marketing Report
Enough of what you can't do online. Gilead Sciences, Novartis, UCB, Shire and Bayer HealthCare show us what you can achieve using a combination of Twitter, Facebook, YouTube, websites, gaming and live events
MM&M New Drug Dossier
MM&M's New Drug Dossier combines promotional insights with clinical information to offer marketers the first complete online resource for newly approved drugs. Click here to sign up for a year's subscription at the special introductory rate of $275 and get unlimited access to the MM&M New Drug Dossier online archive and email alerts.